RNA, 7SL, cytoplasmic 460, pseudogene (RN7SL460P)

RNA, 7SL, cytoplasmic 460, pseudogene (RN7SL460P) is a pseudogene in the human genome that shares high sequence similarity with the functional 7SL RNA gene, a crucial component of the signal recognition particle (SRP) complex responsible for directing secretory and membrane proteins to the endoplasmic reticulum[1][5][7][8]. However, as a pseudogene, RN7SL460P is not functional and does not encode a protein or active RNA product; it is a truncated, non-expressed derivative resulting from the reverse transcription and genomic reintegration of a 7SL RNA sequence[3][5][7]. Most 7SL pseudogenes, including RN7SL460P, arise by retrotransposition and do not have a known biological function or role in disease, nor are they considered therapeutic targets, receptors, enzymes, or biomarkers[5][7][8]. They are not associated with drug targeting or mechanisms of action[1][6][8]. Notes on correctness: - This entry is not a true therapeutic target, receptor, enzyme, or typical functional gene. - It is a “processed pseudogene” and typically is not transcribed or translated into a functional product[1][5][8]. - No role in disease or drug response has been attributed to RN7SL460P specifically; thus, almost all structured output fields are null or not applicable. Summary: RN7SL460P is a non-coding, non-functional processed pseudogene related to 7SL RNA, with no known therapeutic or diagnostic relevance[1][5][8].

Other names

RN7SL460P